Since initially described in 1967, prostatic ductal adenocarcinoma(PDA) has engendered a series of controversies on its origin, histological features, and biolo
Objective: Bone morphogenetic protein receptor 2(BMPR2) and hypoxia-inducible factor 1-α(HIF1-α) existed abnormal expression in several types of cancer. Howev
The Gleason grading system for prostate adenocarcinoma has evolved from its original scheme established in the 1960s–1970s, to a significantly modified system